Maravai
Careers Portfolio Contact us
Welcome Agenda & Webcast Replay Speaker Bios Videos Supporting Documents
Who we are Leadership Board of Directors Corporate Social Responsibility Maravai Foundation
Investors Overview News & Events Company Info Financial Info Stock Data SEC Filings ESG Governance
Skip to main content Skip to section navigation Skip to footer
Maravai
Who we are Who we are Leadership Board of Directors Corporate Social Responsibility Maravai Foundation Investors Overview News & Events Company Info Financial Info Stock Data SEC Filings ESG Governance Careers Portfolio Contact us
Welcome Agenda & Webcast Replay Speaker Bios Videos Supporting Documents

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Executive Team
    • Contacts
    • FAQ
  • Financial Info
    • Quarterly Results
    • Annual Reports & Proxy Statements
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
  • ESG
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Whistleblower Policy
  • News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
May 10, 2021 4:05pm EDT

Maravai Lifesciences Reports First Quarter Financial Results and Updates 2021 Financial Guidance

May 05, 2021 4:10pm EDT

Maravai LifeSciences Announces Investor Conference Schedule for the Month of May 2021

Apr 13, 2021 4:15pm EDT

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 10, 2021

Apr 12, 2021 4:30pm EDT

Maravai LifeSciences Announces Closing of Secondary Offering of Class A Common Stock by Selling Stockholders and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Apr 07, 2021 8:20pm EDT

Maravai LifeSciences Announces Pricing of an Upsized Secondary Offering of Class A Common Stock by Selling Stockholders

Apr 05, 2021 5:30pm EDT

Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders

Apr 05, 2021 4:05pm EDT

Maravai LifeSciences Announces Preliminary Unaudited First Quarter Revenues and Income From Operations Range

Mar 15, 2021 8:05am EDT

Maravai LifeSciences Offers End-to-End mRNA Production with the Launch of TriLink BioTechnologies' Plasmid DNA Manufacturing Services

Mar 02, 2021 4:05pm EST

Maravai LifeSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Initiates 2021 Financial Guidance

Mar 01, 2021 7:05am EST

Maravai LifeSciences Announces March 2021 Investor Conference Schedule

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
Maravai LifeSciences
10770 Wateridge Circle Suite 200
San Diego, CA 92121

Privacy Notice

PO Terms

Copyright © 2023 Maravai LifeSciences Holdings, Inc.
Maravai
Maravai
info@maravai.com
Hours
 

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.